MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

Femasys Inc. raises $4m

January 17, 2017 By Sarah Faulkner Leave a Comment

Femasys Inc. said last week that it raised $4 million, according to a regulatory document filed with the SEC. Atlanta-based Femasys wrote that 8 investors contributed to the round and that it paid Los Angeles-based investment bank Salem Partners LLC an estimated $200,000 in sales commissions. The 1st sale in the financing round happened on Jan. 6 […]

Filed Under: Funding Roundup, Gynecological, Wall Street Beat, Women's Health Tagged With: Femasys Inc.

Femasys raises $40m Series C for FemBloc permanent female contraception device

December 29, 2016 By Brad Perriello Leave a Comment

Femasys said earlier this month that it closed on a Series C round worth $40 million it plans to use on a pivotal trial of its FemBloc permanent female contraception device now that it has FDA approval for the study. Atlanta-based Femasys said the round was arranged and led by Los Angeles-based investment bank Salem Partners, with […]

Filed Under: Funding Roundup, Wall Street Beat, Women's Health Tagged With: Femasys Inc.

Cardiac Dimensions taps ex-AccessClosure chief Casciaro for CEO | Personnel Moves

December 17, 2015 By Brad Perriello Leave a Comment

Cardiac Dimensions said this week that it tapped the former chief of AccessClosure, Gregory Casciaro, to be its new president & CEO. Casciaro led AccessClosure until its May 2014 acquisition by Cardinal Health (NYSE:CAH) for $320 million. His résumé includes stints as the chief executive at drug-eluting stent maker Xtent, Orquest (acquired JNJ’s DePuy Acromed in 2003) […]

Filed Under: Business/Financial News Tagged With: Cardiac Dimensions Inc., Cellnovo, Delphinus Medical Technologies Inc., dextera, Femasys Inc., Grifols, Masimo, NVision, Personnel Moves, Procyrion, Signostics

Report: Medtronic to shutter Ventor’s Israeli shop | Wall Street Beat

March 23, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Medtronic (NYSE:MDT) is shutting down heart valve maker Ventor Technologies, which it acquired in 2009, and moving its R&D efforts to other site, according to an Israeli business journal.

Netanya, Israel-based Ventor is developing an aortic replacement valve called the Engager. Medtronic bought the company for $325 million 3 years ago.

Filed Under: Mergers & Acquisitions, News Well, Replacement Heart Valves, Wall Street Beat Tagged With: Bayer, Edwards Lifesciences, Emerge Medical, Empire Investment Holdings, Femasys Inc., Intuitive Surgical, Kensey Nash Corp., Medidata Solutions, MSI Surgical, Premier Inc., Reva Medical Inc., Synergy Health, Ventor Technologies, Volcano Corp.

Staar Surgical lands European approval for NanoFLEX | Regulatory Roundup

November 17, 2011 By MassDevice staff Leave a Comment

staar

Staar Surgical Co. (NASDAQ:STAA) landed CE Mark approval in the European Union for its nanoFLEX Toric IOL for use in cataract patients with astigmatism.

First shipments of the nanoFLEX intraocular lens are scheduled to roll out to the European market in the first quarter of 2012.

Filed Under: 510(k), Food & Drug Administration (FDA), News Well Tagged With: CorMatrix Cardiovascular Inc., Femasys Inc., Investigational Device Exemption (IDE), Philips, Regulatory Roundup, STAAR Surgical Co, W.L. Gore & Associates

GE Healthcare begins PMA process for 3D breast scanner | Regulatory Roundup

November 11, 2011 By MassDevice staff Leave a Comment

GE Healthcare's Senographe Essential

GE Healthcare (NYSE:GE) filed the first module of its pre-market approval application for the breast tomosynthesis option of its Senographe Essential system.

The health care giant said the first submission included a device description and non-clinical information, including "phantom testing," and detector performance evaluation. The system is intended as an add-on option for the Senographe Essential to produce 3D images for screening and diagnosis of breast cancer.

Filed Under: 510(k), News Well, Pre-Market Approval (PMA) Tagged With: Biolase, Boston Scientific, Centers for Medicare and Medicaid Services (CMS), Cordis Corp., Cytomedix Inc., Diopsys Inc., Ethicon, Femasys Inc., Fresenius, GE Healthcare, Hologic, i-Optics, IDEV Technologies Inc., IntraPace Inc., Johnson and Johnson, Maquet Cardiovascular LLC, Nephros, Ozics Group, Regulatory Roundup, TriVascular, U-Systems, Verisante Technology

Boston Scientific, Medtronic extend atrial fibrillation treatment offerings with new approvals

May 3, 2011 By MassDevice staff Leave a Comment

Medtronic

Boston Scientific Corp. (NYSE:BSX) and Medtronic Inc. (NYSE:MDT) both announced regulatory approvals for new products that will expand their atrial fibrillation treatment offerings.

Natick, Mass.-based Boston Scientific won CE Mark approval for its Blazer open-irrigated, a radiofrequency ablation (RFA) catheter for treating atrial fibrillation and other arrhythmias.

Filed Under: 510(k), News Well, Pre-Market Approval (PMA) Tagged With: Boston Scientific, Femasys Inc., Idaho Technology Inc., Kelyniam Global Inc.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS